The patient was taken to the operating room, and the supraceliac aorta was accessed through the lesser omental sac. We decided to use the splenic artery for the SMA bypass since splenic perfusion was supported from the short gastric arteries. The celiac and splenic artery were explored, and the splenic artery was mobilized from the origin to the splenic hilum over the upper edge of the pancreas. The pancreatic branches of the splenic artery were then ligated and divided. Next, the SMA was explored from the posterior of the pancreas, and it was dissected through the distal portion in order to place a vascular clamp. There was no pulsation in the SMA. Heparin (75 IU/kg) was injected intravenously, and the splenic artery was ligated and transected near the splenic hilum. A longitudinal arteriotomy was then performed on the SMA, and there was backflow from the distal portion of the artery. In our case, the proximal part of the SMA was occluded. Therefore, a vascular clamp was placed only on the distal portion, and the splenic artery was anastomosed end-to-side to the SMA (Figure 2). The spleno-mesenteric bypass was checked intraoperatively by palpation of arterial pulsation, and the SMA pulse was present. The splenic perfusion was normal, so there was no need for a splenectomy.
Anticoagulation therapy was continued during the early postoperative periods, and the patient’s recovery was uneventful. The postprandial abdominal pain of the patient regressed. A control computed tomography (CT) angiography performed on the postoperative fourth day showed that the spleno-SMA bypass was patent (Figures 3), and the patient was discharged without any symptoms on the same day. At the six-month follow-up examination, the patient had no complaints and had gained weight.
The gold standard diagnostic procedure for CMI remains conventional angiography (CA) in clinical practice. Alternatively, CT angiography, magnetic resonance (MR) angiography, or Doppler USG can be used as noninvasive diagnostic procedures.[2] In our patient, the diagnosis was made by CT angiography before performing CA. Conventional angiography was performed in the same session to apply endovascular intervention.
The aim of the treatment is to eliminate symptoms such as postprandial abdominal pain and weight loss and prevent the development of acute intestinal ischemia with the restoration of intestinal perfusion. Therapeutic options for patients with CMI include medical therapy along with surgical and endovascular interventions. Endovascular interventions are treatment modalities that can be easily performed with low morbidity and short hospitalization periods.[5-8] Nevertheless, the long-term results of surgical bypass procedures are better than for endovascular interventions.[5,7-10] We decided to perform an endovascular intervention in our case because it is a less invasive modality. However, in our case, a guide wire was not able to pass through the occlusion of the SMA, so bypass surgery was necessary.
Surgical revascularization for the treatment of CMI uses different operative techniques, for example an endarterectomy, vessel reimplantation, or mesenteric bypass.[1,11] In general, antegrade mesenteric bypass grafting may be performed from either the supraceliac aorta or distal thoracic aorta and retrograde grafting from either the infrarenal aorta or common iliac artery. A prosthetic graft or saphenous veins are commonly used to bypass the SMA. Superficial femoral vein or basilic vein grafts can be also used for the mesenteric bypass in rare cases.[1,10,11] In addition, a superior mesenteric artery bypass with the splenic artery is another antegrade revascularization technique for the surgical treatment of CMI.[6] The celiac artery should be patent to perform a splenic artery-to-SMA bypass. The results of antegrade bypass methods have been superior to those for retrograde bypass methods.[5,6,8,12] Moreover, the splenic artery is an arterial conduit.
The risk of anastomotic stenosis is higher with an autogenic vein or prosthetic graft rather than with a splenic artery due to the requirement of double (proximal and distal) anastomosis in mesenteric bypass surgery. Moreover, the risk of anastomotic stenosis is less with the use of the splenic artery due to the necessity of only a single anastomosis. On the other hand, when these grafts are used for the SMA bypass, some complications may occur due to the crossclamping of the aorta, such as declamping hypotension, which triggers cardiac ischemia, and aortic tissue damage. However, the use of the splenic artery can lead to splenic perfusion defects, which can result in the need for a splenectomy.[5,6] We preferred to use the splenic artery for the advantages of the single anastomosis and arterial conduit. Additionally, we performed a splenic artery-to-SMA bypass because splenic perfusion was supported from the short gastric arteries.
In conclusion, surgical bypass procedures and endovascular interventions provide adequate intestinal perfusion in the treatment of patients with CMI; however, the long-term results of surgical bypass procedures are better. In our case, we performed antegrade mesenteric bypass surgery via the splenic artery. The advantages of this surgical method are that there is no need for a prosthetic, autogenic vein graft and that cross-clamping of the aorta is unnecessary since the antegrade bypass method uses an arterial conduit.
Declaration of conflicting interests
The authors declared no conflicts of interest with
respect to the authorship and/or publication of this article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Sreenarasimhaiah J. Chronic mesenteric ischemia. Curr
Treat Options Gastroenterol 2007;10:3-9.
2) Zacho HD, Abrahamsen J. Chronic intestinal ischaemia:
diagnosis. Clin Physiol Funct Imaging 2008;28:71-5.
3) Soga Y, Yokoi H, Iwabuchi M, Nobuyoshi M. Endovascular
treatment of chronic mesenteric ischemia. Circ J
2008;72:1198-200.
4) Geroulakos G, Tober JC, Anderson L, Smead WL. Antegrade
visceral revascularisation via a thoracoabdominal approach
for chronic mesenteric ischaemia. Eur J Vasc Endovasc Surg
1999;17:56-9.
5) Özer MT, Uzar Aİ, Özal E, Menteş Ö, Bingöl H, Harlak
A ve ark. Superior mesenteric artery obstructıon and
treatmant with mesenteroiliac bypass. Anatol J Clin Investig
2009;3:148-50.
6) Mukherjee D, Hendershot KM. Splenic artery-to-superior
mesenteric artery bypass for chronic mesenteric ischemia--a
case report. Vasc Endovascular Surg 2004;38:465-8.
7) Emrecan B, Önem G, Baltalarlı A. İntestinal anjina:
Karın ağrısının ender bir nedeni. Turk Gogus Kalp Dama
2008;16:269-73.
8) Inoue Y, Sugano N, Iwai T. Long-term results of aortasuperior
mesenteric artery bypass using a new route. Surg
Today 2004;34:658-61.
9) Loffroy R, Guiu B, Cercueil JP, Krausé D. Chronic mesenteric
ischemia: efficacy and outcome of endovascular therapy.
Abdom Imaging 2010;35:306-14. doi: 10.1007/s00261-009-
9515-x.
10) Davies RS, Wall ML, Silverman SH, Simms MH, Vohra
RK, Bradbury AW, et al. Surgical versus endovascular
reconstruction for chronic mesenteric ischemia: a
contemporary UK series. Vasc Endovascular Surg
2009;43:157-64. doi: 10.1177/1538574408328665.